# Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)

> **NCT02954458** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 61 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** TED
- **OTHER:** SOC
- **DEVICE:** Syringe
- **DEVICE:** Needle

## Key facts

- **NCT ID:** NCT02954458
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-09
- **Primary completion:** 2020-11-05
- **Final completion:** 2020-11-05
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2025-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02954458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02954458, "Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02954458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*